RxDoctor Payments Data

Nanah Sesay

Psychiatric/Mental Health · Woodbridge, VANPI 1306171145

Payments from drug & device makers

$3,746in general payments, 2019–2025

Across 173 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$617
  • AbbVie$487
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$445
  • Vanda Pharmaceuticals Inc.$360
  • Otsuka America Pharmaceutical, Inc.$358
  • Johnson & Johnson$334
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$3,58896%
  • Education$1584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,746 in reported general payments places this provider in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia

Medicare billing

Part B allowed, 2024
$11,462
Medicare patients
45
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate64$172,262
IngrezzaValbenazine Tosylate11$87,424
Abilify MaintenaAripiprazole31$74,263
Clozapine49$3,783
Aripiprazole66$3,542
Divalproex Sodium50$1,793
Trazodone Hcl127$1,716
Naltrexone Hcl23$1,676
Divalproex Sodium ErDivalproex Sodium32$1,198
Quetiapine Fumarate40$1,137
Fluoxetine Hcl74$893
Mirtazapine48$769
Hydroxyzine Pamoate65$731
Guanfacine Hcl13$716
Buspirone Hcl46$681

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$334$172,26264 claims
Neurocrine Biosciences, Inc.Ingrezza$310$87,42411 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$358$74,26331 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.

Other psychiatric/mental health in Woodbridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →